Scripps researchers have designed a bacterium with two unnatural bases, called X and Y, which could someday help them produce new molecules for medical therapies

Research led by scientists at the University of Birmingham shows more precisely how G protein-coupled receptors, which are the key target of a large number of drugs, work

Articles in the December 2017 special issue of SLAS Discovery present a snapshot of innovation in the MALDI application space as it stands today

Invitrogen TrueCut Cas9 Protein v2 is a next generation CRISPR-Cas9 protein designed to deliver maximum editing efficiency in a broad range of cells

New cas9 protein and synthetic gRNA strengthen Thermo Fisher Scientific's portfolio of genome editing products

Selective C-H functionalization holds particular promise for the pharmaceutical industry

A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs

Technique may predict which therapies a patient is most sensitive or resistant to

Drugs designed to halt cancer growth may offer a new way to control high blood pressure

The advanced breath simulators, the BRS 2100 and BRS 3100, are designed for orally inhaled product (OIP) development and testing

NitroSynapsin is intended to restore an electrical signaling imbalance in the brain found in virtually all forms of autism spectrum disorder

A recent study shows that there are no negative effects from having annual influenza vaccination